MEA Antinuclear Antibody Test Market

MEA Antinuclear Antibody Test Market Size & Growth (2023 to 2028):

As per the research report, the size of the Middle East and Africa Antinuclear Antibody Test Market is valued at USD 80.02 million in 2022 and expected to reach USD 128.30 million by 2028 at a CAGR of 9.90% during the forecast period 2023 to 2028.

The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody test is a primary test to check a person’s autoimmune disorders. Autoimmune disorders can affect many tissues and organs in the body. This test is most often used to diagnose the Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis.

Factors such as an increase in the prevalence of autoimmune diseases, such as rheumatoid arthritis and SLE, growing economies in this region and growth in the awareness of people about these diseases, are driving this market. Autoimmune diseases can also cause type I diabetes. Other factors such as, increase in healthcare expenditure of people due to growing economies, and government healthcare insurance & reimbursement policies are fuelling this market. On the other hand, factors such as poor economies in this region, war regions, diagnostic errors, product approval, and unavailability of skilled labor are hindering the growth of this market.

This research report on the MEA Antinuclear Antibody Test Market has been segmented and sub-segmented into the following categories:

By Disease:

• SLE
• Rheumatoid Arthritis

By Technique:

• Immunofluorescence
• Multiplex
• ELISA

By Product:

• Software
• Systems
• Services
• Reagents
• Assay Kits

By End User:

• Hospitals
• Clinical Labs

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

The Middle East and Africa. Africa is growing at a faster rate compared to the Middle East. Because of being affected by wars and most of the countries have poor economies, the market is not that big in this region. Because of very few competitors in this region, opportunities for the new and upcoming companies are huge.

The leading companies leading in the MEA Antinuclear Antibody Test Market profiled in the report are  Zeus Scientific Inc., Inova Diagnostics, Immuno Concepts, Euroimmun AG, Antibodies Inc., Thermo Fisher Scientific Inc., Trinity Biotech plc, ERBA Diagnostics Inc., Bio-Rad Laboratories Inc., and Alere Inc.